Delivery Order 75N95023D00025-75N95026F00001
- Not listed
- The National Institute on Drug Abuse (NIDA) awarded a $394.5K delivery order contract to CCS Associates, Inc., a woman-owned small business based in San Jose, California, for regulatory preparation, review, and submission support associated with clinical trials under the NIDA Drug Supply Program. The contract runs from April 1, 2025 through March 31, 2026 and is structured as a cost-plus-fixed-fee arrangement with no set-aside designation. CCS Associates specializes in regulatory affairs and...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $495.8K labor-hour purchase order to CCS Associates, Inc., a woman-owned small business based in San Jose, California, for regulatory affairs consulting support services. The contract, set aside for small businesses and effective through September 2026, will be performed primarily in Rockville, Maryland, with occasional on-site work. Under the original solicitation, CCS Associates will provide...
- This is a Delivery Order contract awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to CCS Associates, Inc., a woman-owned small business. The contract is for REGULATORY AFFAIRS SUPPORT services with a period of performance from April 1, 2024 to March 31, 2025 and a ceiling value of $307,737.00. This contract does not have a set-aside designation. CCS Associates is an experienced provider of research support services to federal agencies,...
- This is a $1,172,492.63 firm fixed-price federal contract awarded by the Food and Drug Administration (FDA) to CCS Associates, Inc., a woman-owned small business based in San Jose, California. The contract is a set-aside for small businesses and has an ultimate completion date of September 29, 2026. Under this contract, CCS Associates will provide the FDA with a variety of regulatory affairs, scientific consulting, and research support services. This includes preparing regulatory documents,...
- The National Institute on Drug Abuse (NIDA) awarded a delivery order contract to Capital Consulting Corp, a minority-owned, woman-owned, veteran-owned, and service-disabled veteran-owned small business based in Fairfax, Virginia, on November 1, 2023. This contract, set aside for small businesses, provides clinical program support for the NIDA Intramural Research Program (IRP), specifically covering participant remuneration, travel, and subsistence costs. The contract carries a ceiling value of...
- The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $16,000 purchase order to Cellx, Inc., a small business, on September 29, 2025, for pharmaceutics formulation, chemistry manufacturing and controls (CMC) consulting services supporting drug discovery and development programs. The contract, which runs through September 28, 2028, provides specialized subject matter expert consultation for small molecules and biologics development, with...
- This $548,714.60 firm fixed-price delivery order contract was awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services, to CCS Associates, Inc., a woman-owned small business. The contract is for TAS (Task Area Support) to provide strategic planning and activities support for NCI's Center for Strategic Scientific Initiatives (CSSI). CCS Associates specializes in providing comprehensive research support services to federal agencies,...
- The U.S. National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, has awarded a $136,232.50 firm-fixed-price delivery order to Synectics For Management Decisions, Inc., a woman-owned small business. This delivery order was issued under the Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB) government-wide acquisition contract. The contract will provide web developer services to support NIDA's research programs...
- This is a delivery order contract awarded to CCS Associates, Inc., a woman-owned small business, by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The $3,882,241.70 firm fixed price contract provides administrative support services to the NCI. CCS Associates has secured numerous federal contracts and grants to assist government agencies in advancing medical research and drug development...
- This is a $4,026,071.62 cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, to SD Solutions LLC, an 8(a) small disadvantaged business based in Rockville, Maryland. The contract is for the NIDA Clinical Trials Research Coordination Center, which will provide logistical and operational support services for NIDA's National Drug Abuse Treatment Clinical Trials Network. This includes coordinating meetings,...
- 75N95023D00025Indefinite Delivery Contract
- 75N95023D00025-75N95026F00001Delivery Order
The National Institute on Drug Abuse (NIDA) awarded a delivery order valued at $209,529 to CCS Associates, Inc., a woman-owned small business headquartered in San Jose, California, for regulatory preparation, review, and submission services associated with clinical trials under the NIDA Drug Supply Program. The contract period runs from March 27, 2026 through March 26, 2027, and is structured as a cost-plus-fixed-fee arrangement with no set-aside designation. CCS Associates specializes in regulatory affairs support and scientific consulting for federal biomedical research agencies, with particular expertise in preparing regulatory submissions including Investigational New Drug (IND) and Pre-IND applications for drug development programs. This delivery order is issued under a larger $2.4 million single-award Indefinite Delivery Vehicle (IDV) contract between CCS Associates and NIDA for regulatory affairs support services through September 2028. The company's work on this specific delivery order will support NIDA's clinical trial initiatives by providing comprehensive regulatory documentation and submission support services, leveraging CCS Associates' established track record of supporting multiple National Institutes of Health agencies and the Food and Drug Administration in complex drug development and regulatory compliance activities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $209.5k | 3/24/26 |